Aguirre Jarrad Mattieu
Reporting owner on Forms 3, 4 and 5, CIK 2150331.
Aguirre Jarrad Mattieu reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-13.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| LYEL · Lyell Immunopharma, Inc.CIK 1806952 | officer (Chief Medical Officer) | 1 | 2026-10-13 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| LYEL · Lyell Immunopharma, Inc.Common Stock | 2026-10-12 | S sold | -422 | $8.63 | 19,857 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002150331-26-000003 | Lyell Immunopharma, Inc. | 2026-10-13 |